AtriCure, Inc. (ATRC)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | 136,139 | 123,620 | 115,910 | 116,269 |
| Cost of revenue | 34,657 | 30,992 | 29,117 | 29,425 |
| Gross profit | 101,482 | 92,628 | 86,793 | 86,844 |
| Selling, general and administrative expenses | 78,390 | 76,054 | 73,238 | 73,596 |
| Research and development expenses | 29,284 | 22,528 | 20,960 | 20,416 |
| Total operating expenses | 107,674 | 98,582 | 94,198 | 94,012 |
| Loss from operations | -6,192 | -5,954 | -7,405 | -7,168 |
| Interest income | 941 | 1,042 | 1,281 | 997 |
| Interest expense | 1,490 | 1,416 | 1,667 | 1,612 |
| Loss on debt extinguishment | - | - | - | - |
| Other income (expense) | 812 | -180 | 260 | 28 |
| Loss before income tax expense | -5,929 | -6,508 | -7,531 | -7,755 |
| Income tax expense | 261 | 239 | 322 | 253 |
| Net loss | -6,190 | -6,747 | -7,853 | -8,008 |
| Unrealized gain on investments | - | - | 15 | 246 |
| Foreign currency translation adjustment | 979 | 805 | 407 | -118 |
| Other comprehensive income | 979 | 805 | 422 | 128 |
| Comprehensive loss, net of tax | -5,211 | -5,942 | -7,431 | -7,880 |
| Basic net loss per share (in usd per share) | -0.13 | -0.14 | -0.17 | -0.17 |
| Diluted net loss per share (in usd per share) | -0.13 | -0.14 | -0.17 | -0.17 |
| Weighted average shares outstandingbasic (in shares) | 47,721,000 | 47,393,000 | 47,105,000 | 46,909,000 |
| Weighted average shares outstandingdiluted (in shares) | 47,721,000 | 47,393,000 | 47,105,000 | 46,909,000 |